USE OF CONTINGENCY TABLE IN DECISION MAKING DURING PHASE I TOLERANCE STUDY

dc.contributor.authorVELASCO, LR
dc.contributor.authorJOUBERT, L
dc.date.accessioned2026-05-28T16:39:58Z
dc.date.issued1975
dc.description.paginacion237 - 237
dc.description.procedenciaEXT
dc.format.discursoResumen de reunión
dc.format.extent1
dc.identifier.issn0009-9236
dc.identifier.urihttps://ahcm.cinvestav.mx/handle/ahcm/25857
dc.language.isoInglés
dc.numero.secuencia25854
dc.publisherWINTHROP PROD INC,NEW YORK,NY
dc.publisherINST MEXICANO SEGURO,PEDIAT HOSP,MEXICO CITY,MEXICO
dc.relation.ispartofseriesVol. 17 No. 2
dc.source.revistafuenteCLINICAL PHARMACOLOGY & THERAPEUTICS
dc.subjectUSE, CONTINGENCY, TABLE, DECISION MAKING, TOLERANCE, STUDY
dc.subject.categoriaprincipalCIENCIAS MEDICAS
dc.subject.disciplinaFARMACOLOGIA
dc.subject.subdisciplinaFARMACOLOGIA EXPERIMENTAL
dc.titleUSE OF CONTINGENCY TABLE IN DECISION MAKING DURING PHASE I TOLERANCE STUDY
dc.title.alternativeCLIN PHARMACOL THER

Files